Medicare Enrolled

Dr. Kathy Wilson, M.D.

Pulmonary Disease · Conover, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3521 GRAYSTONE PL SE, Conover, NC 28613
8283262660
In practice since 2006 (19 years)
NPI: 1114095841 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wilson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wilson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wilson

Dr. Kathy Wilson is a pulmonary disease specialist in Conover, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wilson performed 429 Medicare services across 271 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wilson received a total of $13,730 from 41 pharmaceutical and/or device companies across 278 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wilson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 429 Medicare services $13,730 industry payments

Medicare Practice Summary

Medicare Utilization ↗
429
Medicare services
Bottom 38% in NC for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
271
Unique beneficiaries
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~23 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
186 $162 $550
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
79 $86 $314
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
45 $90 $258
Sleep study with continuous airway pressure, age 6+
A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older.
42 $93 $316
Sleep study with heart rate and breathing monitoring
A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function.
25 $28 $102
Sleep study in sleep lab (age 6+)
An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older.
21 $81 $305
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
17 $52 $222
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
14 $126 $500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,730
Total received (2018-2024)
Avg $1,961/year across 7 years
Top 13% in NC for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
278
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$8,756 (63.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,974 (36.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$350
2023
$234
2022
$1,434
2021
$5,114
2020
$3,759
2019
$1,501
2018
$1,337

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
HARMONY BIOSCIENCES LLC
$73
Inspire Medical Systems, Inc.
$42
AstraZeneca Pharmaceuticals LP
$37
Mylan Specialty L.P.
$37
ANI Pharmaceuticals, Inc.
$32
Harmony Biosciences Llc
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
Amgen Inc.
$18
Fisher & Paykel Healthcare Inc
$17
Regeneron Healthcare Solutions, Inc.
$16
Nuwellis, Inc.
$14
GlaxoSmithKline, LLC.
$13
Top 3 companies account for 43.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$9,309
Actelion Pharmaceuticals US, Inc.
$1,199
GlaxoSmithKline, LLC.
$696
Boehringer Ingelheim Pharmaceuticals, Inc.
$440
Philips Electronics North America Corporation
$211
Vapotherm Inc
$147
Sunovion Pharmaceuticals Inc.
$146
Genentech USA, Inc.
$132
Mylan Specialty L.P.
$119
Mallinckrodt LLC
$101
Grifols USA, LLC
$85
HARMONY BIOSCIENCES LLC
$73
Regeneron Healthcare Solutions, Inc.
$71
Insmed, Inc.
$64
Inspire Medical Systems, Inc.
$61
United Therapeutics Corporation
$61
Baxter Healthcare
$60
Paratek Pharmaceuticals, Inc.
$56
Mallinckrodt Enterprises LLC
$53
Amgen Inc.
$51
GENZYME CORPORATION
$49
Electromed, Inc.
$46
AbbVie Inc.
$45
Mallinckrodt Hospital Products Inc.
$43
PORTOLA PHARMACEUTICALS, INC.
$41
CHF Solutions, Inc
$41
Fisher & Paykel Healthcare Inc
$40
Merck Sharp & Dohme Corporation
$37
ANI Pharmaceuticals, Inc.
$32
Harmony Biosciences Llc
$27
PFIZER INC.
$25
Gilead Sciences, Inc.
$25
Tactile Systems Technology Inc
$23
ABBVIE INC.
$22
Inogen, Inc.
$18
Allergan Inc.
$15
Janssen Pharmaceuticals, Inc
$15
Nuwellis, Inc.
$14
Nabriva Therapeutics, plc
$13
Shire North American Group Inc
$12
Circassia Pharmaceuticals Inc
$11
Top 3 companies account for 81.6% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (8876) Vest Therapy Und · ACTHAR · AIRSUPRA · ANDEXXA · ANORO · AVYCAZ · Aquadex · Aquadex Smartflow Console · Arikayce · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · DUPIXENT · DreamStat Cpap Auto · FASENRA · FISHER & PAYKEL HEALTHCARE · Flexitouch Plus · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Volara System · INSPIRE · InogenOne · LONHALA MAGNAIR · NUCALA · NUZYRA · OFEV · OFIRMEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PURIFIED CORTROPHIN GEL · Precision Flow · Prolastin-C · Prolastin-C Liquid · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · Trilogy 100 · UPTRAVI · Utibron · WAKIX · Wellcentive Undiv · XARELTO · Xenleta · Xolair · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware.

Looking for a pulmonary disease specialist in Conover?
Compare pulmonary diseases in the Conover area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
11
Per 100K population
6.8
County median income
$64,544
Nearest hospital
FRYE REGIONAL MEDICAL CENTER
7.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wilson is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 13% of NC peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wilson experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Wilson performed 186 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wilson receive payments from pharmaceutical companies?
Yes. Dr. Wilson received a total of $13,730 from 41 companies across 278 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wilson's costs compare to other pulmonary diseases in Conover?
Dr. Wilson's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wilson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →